“I believe that one of the most important things that I can do as a legislator and policymaker is look for opportunities and ways to create jobs and improve our economy. That is why I attended and participated in this forum focusing on the creation of jobs in the medical field,” Gentile said.
The meeting discussed establishing and maintaining an Asset Inventory across the state to identify Connecticut organizations and companies working in bioscience, biopharma, biotech, genomics, clinomics, epigenomes, pharmacogenomics, and related fields.
By identifying these organizations, the state can promote business development through competitions that will incentivize firms or individuals located anywhere in the world to come into Connecticut. Furthermore, the state will be able to retain talent and invite and recruit experts in the fields of precision medicine and personalized health work in CT to build a critical mass of talent.
The economic impact of building a cluster and critical mass around precision medicine will have strong and positive effects cross the state.
The Commission on Economic Competitiveness works to analyze the implications of state tax policy on state business and industry and to develop policies that promote economic growth.
(This is a press release from the state House Democrats' office.)